Director, Financial Planning & Analysis

Immunovant, Inc.; United States; Remote; USD 180,000 - 240,000; Full time

Benefits offered by this job

Equity and total compensation package

Medical, dental, vision, 401k

Unlimited paid time off and parental/2

Job summary

Immunovant, Inc. is seeking a senior FP&A professional to own budgets, forecasts and month-end reporting for R&D. You will partner with the CFO and program leaders to drive multi-year financial plans and critical board materials.

In this role, you will develop trial-level cost models, lead quarterly R&D forecasts, and provide strategic analysis to leadership. Advanced Excel, complex modeling and experience with Adaptive, Coupa and NetSuite are highly valued.

Qualifications

• 7+ years in FP&A, investment banking or consulting.
• Advanced Excel and complex modeling skills.
• Strong written and verbal communication in a virtual environment.
• Ability to work independently in a fast-paced environment.
• BA or BS degree required.
• MBA or similar Masters preferred.
• Biotech or pharmaceutical industry experience preferred.
• Experience with Adaptive, Coupa and NetSuite preferred.

Responsibilities

• Own development and monitoring of annual budgets, quarterly forecasts and month-end reporting for R&D.
• Support CFO with multi-year strategic financial plan and Board materials.
• Own trial-level clinical cost models and key study assumptions.
• Lead the R&D quarterly forecast cycle with clinical and program leaders.
• Partner with Accounting on R&D month-end close and variance analysis.
• Evaluate CRO and vendor proposals and contracts against forecast and cash flow.
• Provide business and financial analysis and decision support to leadership.
• Build reports, analytics and monthly R&D financial reviews.

Skills

Advanced Excel

Complex modeling

Financial analysis

Independent work

Education

BA/BS degree

MBA or Master’s

Tools

Adaptive

Coupa

NetSuite

Job description

Responsibilities

• Own development and monitoring of annual budgets, quarterly forecasts and month-end reporting for R&D


• Support CFO with multi-year strategic financial plan and Board materials


• Own trial-level clinical cost models and key study assumptions


• Lead the R&D quarterly forecast cycle with clinical and program leaders


• Partner with Accounting on R&D month-end close and variance analysis


• Evaluate CRO and vendor proposals and contracts against forecast and cash flow


• Provide business and financial analysis and decision support to leadership


• Build reports, analytics and monthly R&D financial reviews

Requirements

• 7+ years in FP&A, investment banking or consulting


• Advanced Excel and complex modeling skills


• Strong written and verbal communication in a virtual environment


• Ability to work independently in a fast-paced environment


• BA or BS degree required

Preferred Qualifications

• MBA or similar Masters


• Biotech or pharmaceutical industry experience


• Experience with Adaptive, Coupa and NetSuite

Benefits

• Equity and total compensation package


• Medical, dental, vision, 401k


• Unlimited paid time off and parental leave

About the Company

Immunovant is a clinical-stage biopharmaceutical company developing FcRn inhibitor therapies for autoimmune diseases.